Live News EQUITY FLASH M impact Nov 20, 2026, 02:30 PM UTC AIM ImmunoTech CEO Equels Acquires $6,550 in Common Shares CEO and President Thomas K. Equels acquired $6,550 in AIM ImmunoTech common shares. AIM SquawkNews Desk